CG
OSIR

Cutler Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Cutler Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-8,700
Closed -$80K – 7967
2016
Q1 		$80K Sell
8,700
-8,100
-48% -$56.6K 0.01% 1839
2015
Q4 		$84K Buy
+16,800
New +$228K ﹤0.01% 1936

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Cutler Group's OSIR Position: Q1 2017 in Review

Cutler Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 13,186 shares — an estimated $64K sold.

Cutler Group first reported a position in OSIR in Q4 2015 and held it in 3 quarters. The position peaked at $82K in Q4 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Cutler Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Cutler Group sold 13,186 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $64K.
  • Cutler Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2015 and held it in 3 quarters.
  • Cutler Group's Osiris Therapeutics, Inc. Common Stock position peaked at $82K in Q4 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.